Healthquest Partners
SlowingBelmont, CAHealthcare, Pharmaceuticals, BiotechnologyLast fund filed March 2022
1 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| HealthQuest Partners IV | March 2022 | $675M | $675M | 109 |
| HealthQuest Partners III | March 2019 | $440M | $440M | 87 |
| HealthQuest Partners II | 2016 | $225M | $225M | 53 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
1 partner is named across this firm’s filings, 1 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Garheng Kong | Slowing | Medical devices, Biotech & pharma, Healthcare services | 17 |
Classified sectors of Healthquest Partners’s own portfolio companies, based on 16 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Healthquest Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Sofinnova Venture Partners | 17 | Ajax Health II, Ajax Health III, Alcresta Therapeutics, ALIMERA SCIENCES, AVEDRO, Bardy Diagnostics, CASTLE BIOSCIENCES, CleanSlate Centers, First Aid Beverages, Home Hospital Newco, Magnolia Medical Technologies, MELINTA THERAPEUTICS, INC. /NEW/, Nomad Health, Strongbridge Biopharma plc, Trice Medical, Venus Concept, Venus Concept |
| Aperture | 3 | AVEDRO, Venus Concept, Venus Concept |
| Domain Partners | 2 | ALIMERA SCIENCES, Trice Medical |
| 1 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| Polaris Partners | 2 | Ajax Health III, Nomad Health |
| Abingworth Bioventures | 1 | AVEDRO |
| Absolute Return | 1 | Magnolia Medical Technologies |
| Aisling Capital | 1 | Ajax Health II |
| Balcera Fund Ltd | 1 | Magnolia Medical Technologies |
| Bessemer Venture Partners | 1 | Alcresta Therapeutics |
| Borealis | 1 | AVEDRO |
| Buckeye Fund Ltd | 1 | Magnolia Medical Technologies |
| Cadence Alternative Investments | 1 | Magnolia Medical Technologies |
| Caduceus Capital | 1 | AVEDRO |
| Cascade Fund Ltd | 1 | Magnolia Medical Technologies |
| Cedar Investments Ltd | 1 | Magnolia Medical Technologies |
A shared board seat: a company where filings name a Healthquest Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.